Influenza (pandemic)

Trump's 'vaccine hesitant’ views run against public opinion, Pew says

As many experts wait anxiously to see how President Donald Trump might act on vaccines, a new survey documents strong support by Americans that the benefits of childhood immunizations outweigh any potential risks.
Pew Research Center reports that 88% of Americans think the benefits of the MMR vaccine outweigh the risks, while one in 10 believe the risks aren’t worth the benefits.
The survey—conducted from May 10 to June 6 last year—found that 82% of Americans are in favor of MMR vaccination requirements for healthy schoolchildren.

La OMS advierte del riesgo de pandemia de gripe

A pesar de los progresos realizados durante los últimos años en la fabricación de vacunas contra la gripe estacional el riesgo de pandemia global se mantiene a un nivel elevado, según la doctora Marie-Paula Kieny, directora del departamento de Sistemas de Salud e Innovación de la Organización Mundial de la Salud (OMS).

Synthetic DNA vax protects 100% of animals susceptible to Zika

For the first time, researchers have tested a Zika vaccine in animals that do not have a natural resistance to the virus. The synthetic DNA jab protected 100% of vaccinated animals from Zika infection, brain damage and death.


Beyond Ebola, keeping patients and health workers safe

Dr Doussou Touré arrives for work at Coléah Medical Centre. She washes her hands from a bucket set up in front of the building, proceeds to a screening area where her temperature is checked and recorded and only then enters the bustling facility that she supervises.
“Ebola is under control now, but we try to keep up the infection prevention and control systems that were put in place during the outbreak,” Dr Touré says, pointing to several sturdy, brightly-coloured bins, each one designated for the disposal of varying waste matter.

China needs tougher enforcement of vaccine regulation: WHO

China must strengthen regulation of its market for vaccines, the World Health Organization (WHO) said on Monday, after a bust of an illegal black market drugs ring this month underscored the country's regulatory weaknesses.
Police have arrested more than 130 suspects over a scandal in which 310 million yuan ($48 million) of illegal vaccines was sold onto the market. The value of the illegal trades could be as much as $90 million.

Afrique: Vaccination infantile - L'Afrique, le continent le moins protégé

La première conférence ministérielle africaine sur la vaccination a ouvert ses travaux, le mercredi 24 février 2016 à Addis Abeba en Ethiopie. Des ministres de la Santé, des Finances, des experts, des décideurs, des bailleurs de fonds et de la société civile réfléchissent aux moyens les plus efficaces afin de parvenir à une couverture vaccinale de tous les enfants du continent.
Etendre la vaccination afin de parvenir à une couverture universelle est le nouveau challenge que les dirigeants africains et leurs partenaires veulent se donner en matière de santé.

Grippe aviaire : le Lot, septième département à être touché

Un septième département vient d’être touché par la grippe aviaire. Il s’agit du Lot, a annoncé, mardi 5 janvier, le ministère de l’agriculture sur son site Internet. Le nombre de foyers d’influenza aviaire hautement pathogène pour les volailles se chiffre désormais à 65 dans le Sud-Ouest de la France.

Roche's influenza A and B tests get federal permission to be used at the point-of-care

Roche's real-time polymerase chain reaction tests for the detection of influenza A and B can now be used in settings such as the emergency room, pharmacies and physicians' offices, thanks to a CLIA waiver exempting it from a set of regulations on large diagnostic laboratories carried out by the federal Centers for Medicare & Medicaid Services.


Scripps Research Institute, J&J test 'universal' flu vaccine in mice, monkeys

The NIAID may have posted 94% efficacy in mice for its investigational "universal" flu vaccine, but The Scripps Research Institute and partner Johnson & Johnson ($JNJ) are hot on its heels. Scripps announced Monday that its most advanced candidate fully protected mice in a lethal challenge. They also conducted a sublethal challenge, where the vaccine reduced fever in monkeys.